BCHE and Alzheimer disease: Inhibitors of cholinesterases and monoamine oxidases have been shown to be therapeutic for Alzheimer’s disease and Parkinson’s disease respectively, and these drugs are used regularly in the clinic to treat symptoms of disease (Reviewed by [234,235]).